Company: INMB
Filing Date: 2025-06-16
Form Type: S-8
Source: 0001213900-25-054428
Chunk: 3

Company: Inmune Bio, Inc.
Filing Date: 2025-06-16
Form: S-8
Chunk 3
---
. Any other expenses incurred by
us in connection with the registration and offering and not borne by the selling stockholders will be borne by us.

This reoffer prospectus has been prepared for
the purposes of registering the shares under the Securities Act of 1933, as amended (the “Securities Act”) to allow for future
sales by selling stockholders on a continuous or delayed basis to the public without restriction.

The selling stockholders and any brokers executing
selling orders on their behalf may be deemed to be “underwriters” within the meaning of the Securities Act, in which event
commissions received by such brokers may be deemed to be underwriting commissions under the Securities Act.

Our common stock is quoted on the Nasdaq Capital
Market under the symbol “INMB.” The last reported sale price of our common stock on the Nasdaq Capital Market on June 12,
2025, was $7.92 per share.

Investing in our common stock involves a high degree of risk. See “Risk Factors” beginning on page 2 of this reoffer prospectus.

Neither the Securities and Exchange Commission (the “SEC”) nor any state securities commission has approved or disapproved of these securities or determined if this reoffer prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

<div align='center'>The date of this reoffer prospectus is June
13, 2025.

TABLE OF CONTENTS</div>

|                                                                                     | Page |
| Cautionary Note Regarding Forward Looking Statements                                |   ii |
| Prospectus Summary                                                                  |    1 |
| Risk Factors                                                                        |    2 |
| Determination of Offering Price                                                     |    3 |
| Use of Proceeds                                                                     |    3 |
| Selling Stockholders                                                                |    3 |
| Plan of Distribution                                                                |    5 |
| Legal Matters                                                                       |    7 |
| Experts                                                                             |    7 |
| Incorporation of Certain Documents by Reference                                     |    7 |
| Disclosure of Commission Position on Indemnification For Securities Act Liabilities |    8 |
| Additional Information Available to You                                             |    8 |

NO PERSON HAS BEEN AUTHORIZED TO GIVE ANY INFORMATION
OR TO MAKE ANY REPRESENTATIONS, OTHER THAN THOSE CONTAINED IN THIS REOFFER PROSPECTUS, IN CONNECTION WITH THE OFFERING MADE HEREBY, AND,
IF GIVEN OR MADE, SUCH INFORMATION OR REPRESENTATION MUST NOT BE RELIED UPON AS HAVING BEEN AUTHORIZED BY